Medifast (MED)
Sells OPTAVIA nutrition plans through independent coaches and direct customer shipping.
$11.98
vs last close−0.10 (−0.83%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 236 | 191 | 175 | 169 | 140 | 119 | 116 | 106 | 89 | 75 | 76 | 76 |
| Cost of revenue | 58 | 50 | 47 | 45 | 34 | 31 | 31 | 29 | 27 | 23 | 24 | 23 |
| Gross profit | 177 | 141 | 127 | 123 | 106 | 88 | 84 | 77 | 62 | 52 | 52 | 53 |
| 152 | 133 | 119 | 131 | 104 | 88 | 86 | 78 | 66 | 60 | 53 | 58 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Selling, general & administrative | 152 | 133 | 119 | 131 | 104 | 88 | 86 | 78 | 66 | 60 | 55 | 58 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −3 | 0 |
| Operating income | 26 | 9 | 8 | −8 | 2 | 1 | −1 | −1 | −4 | −8 | −1 | −4 |
| 1 | 1 | 4 | −3 | −1 | 1 | 2 | 4 | 1 | 1 | −1 | 1 | |
| Interest income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income | 0 | −1 | −4 | 3 | 1 | −1 | −2 | −4 | −1 | −1 | 1 | −1 |
| Income before tax | 27 | 10 | 12 | −11 | 2 | 1 | 1 | 3 | −3 | −6 | −2 | −3 |
| Income tax expense | 3 | 4 | 3 | −2 | 0 | 0 | 1 | 0 | 0 | 12 | 0 | 0 |
| Net income from continuing operations | 23 | 6 | 8 | −8 | 1 | 1 | −1 | 2 | −2 | −18 | −2 | −3 |
| Net income | 23 | 6 | 8 | −8 | 1 | 1 | −1 | 2 | −2 | −18 | −2 | −3 |
| EPS, basic | $2.12 | $0.50 | $0.76 | −$0.75 | $0.10 | $0.07 | −$0.07 | $0.23 | −$0.21 | −$1.65 | −$0.19 | −$0.28 |
| EPS, diluted | $2.12 | $0.50 | $0.76 | −$0.75 | $0.10 | $0.07 | −$0.07 | $0.22 | −$0.21 | −$1.65 | −$0.19 | −$0.28 |
| Weighted average shares, basic | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Weighted average shares, diluted | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| EBITDA | 29 | 13 | 15 | −8 | 5 | 4 | 4 | 7 | 1 | −3 | 2 | −3 |
| Depreciation & amortization | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 0 |
| EBIT | 26 | 10 | 12 | −11 | 2 | 1 | 1 | 3 | −3 | −6 | −2 | −3 |